....and, as for the science.... the TGA considered the previous trial results as being inconclusive or not substantiative enough to conditionally approve the drug.
So anecdotal evidence, very small numbers of participitants in previous trials, and a failed P2 with a nominated lower dose, indicates that we haven't got conclusive evidence yet that iPPS is the "bee's knees" that some in here are claiming.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $118.7M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.0¢ | 29.0¢ | $129.1K | 423.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 61075 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 70433 | 5 |
View Market Depth
| Last trade - 15.49pm 18/06/2025 (20 minute delay) ? |
| PAR (ASX) Chart |